Qual è la capitalizzazione di mercato per Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534)

La capitalizzazione di mercato per Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534) è $661.58M

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534) Prezzo e Capitalizzazione di Mercato

Q: Quale sarebbe il prezzo per Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534)

Il prezzo per Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534) è $2.18

Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd operates as a pharmaceutical enterprise, focusing on the research, development, manufacturing, and commercialization of traditional Chinese medicines, health supplements, and active pharmaceutical ingredients (APIs). Its extensive product line includes therapeutic remedies such as Yuanhu Analgesic dropping pills, Qiwei Wenyang capsules, Maxing cough capsules, Shuxinning tablets, Panax notoginseng pills, Anti-inflammatory and gallbladder tablets, Children's Qingfei cough tablets, Pediatric Qinggan tablets, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, Astragalus Angelica capsules, and berberine tannin films. Beyond its core manufacturing, the company is actively involved in the cultivation, procurement, processing, and distribution of Chinese medicinal raw materials. Its operations further encompass project investment and management, alongside the import, sale, logistics, and export of pharmaceutical goods. Established in 2002, Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd is headquartered in Lanzhou, China.

Il prezzo per 300534	Attivo B	Capitalizzazione del mercato a B	Risultati
$17,352.74 $661.58M	NVDA	$5.264T	+795,549.17%
$15,498.12 $661.58M	AAPL	$4.701T	+710,511.76%
$13,770.39 $661.58M	GOOG	$4.177T	+631,292.77%
$12,584.35 $661.58M	MSFT	$3.817T	+576,911.47%
$9,449.10 $661.58M	AMZN	$2.866T	+433,155.29%

Il prezzo per 300534

Attivo B

Capitalizzazione del mercato a B

Risultati

$17,352.74 $661.58M